These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3166893)

  • 1. Studies on the activity of a protease associated with cells at the advancing edge of human tumour masses in frozen sections.
    Steven FS; Griffin MM; Maier H; Weidauer H; Mangel WF; Altmannsberger M
    Br J Cancer; 1988 Jul; 58(1):57-60. PubMed ID: 3166893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of guanidinobenzoatase by a substrate for trypsin-like enzymes.
    Steven FS; Griffin MM; Mangel WF; Maier H; Altmannsberger M
    J Enzyme Inhib; 1988; 2(3):209-14. PubMed ID: 2467971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The status of trypsin-like enzymes in squamous-cell carcinoma of the head and neck region.
    Steven FS; Williams LA; Maier H; Arndt J; Weidauer H; Born A
    J Cancer Res Clin Oncol; 1990; 116(1):57-64. PubMed ID: 2312606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of guanidinobenzoatase and their possible role in cell migration.
    Steven FS; Griffin MM
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():137-43. PubMed ID: 3202961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of guanidinobenzoatase: evidence for multiple forms of this protease on different tumour cells.
    Steven FS; Griffin MM; Freemont AJ; Johnson J
    J Enzyme Inhib; 1988; 2(2):117-27. PubMed ID: 3236068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the functional similarity between tumour cell surface guanidinobenzoatase and tissue type plasminogen activator.
    Steven FS; Griffin MM; Cederholm-Williams SA; Mangel WF; Maier H
    Anticancer Res; 1991; 11(2):641-7. PubMed ID: 1905903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fluorescent study of ligands for guanidinobenzoatase, a protease associated with tumour cells.
    Steven F; Griffin MM; Williams LA; Feichter G
    Anticancer Res; 1988; 8(6):1179-83. PubMed ID: 3218954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association and dissociation of a protease and its inhibitor on the surface of lung squamous cell carcinoma cells.
    Steven FS; Anees M; Myers J; Hasleton P
    Anticancer Res; 1993; 13(4):1063-8. PubMed ID: 8352526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the interaction and exchange of inhibitors and proteases on the surface of tumour cells in frozen sections.
    Steven FS; Griffin MM; Bulleid NJ; Maier H; Born IA
    Anticancer Res; 1991; 11(6):2117-22. PubMed ID: 1776849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple fluorescent technique for the location of tumour cells in frozen sections of the head and neck region.
    Steven FS; Griffin MM; Maier H; Born A; Zoeller J
    Anticancer Res; 1991; 11(3):1189-94. PubMed ID: 1716085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent location of human colonic tumour cells by means of an enzyme-inhibitor complex.
    Steven FS; Maier H; Talbot IC
    J Enzyme Inhib; 1990; 3(3):229-36. PubMed ID: 2079640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further inhibition studies on guanidinobenzoatase, a trypsin-like enzyme associated with tumour cells.
    Steven FS; Griffin MM; Wong TL; Yasmin R; Mangel WF
    J Enzyme Inhib; 1987; 1(3):187-201. PubMed ID: 3334244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of the proteolytic enzyme guanidinobenzoatase in human basal cell carcinoma.
    Steven FS; Maier H; Born A; Weidauer H
    ORL J Otorhinolaryngol Relat Spec; 1989; 51(6):360-4. PubMed ID: 2480560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of fluorescent probes for an enzyme on the surface of tumour cells.
    Steven FS; Griffin MM; Al-Ahmad RK
    J Chromatogr; 1986 Apr; 376():211-9. PubMed ID: 3711193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitor reacting with a tumour cell surface protease can be exchanged with plasminogen activator inhibitor (PAI-1).
    Steven FS; Booth NA
    J Enzyme Inhib; 1991; 4(3):273-9. PubMed ID: 2037870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for inhibitors of the cell surface protease guanidinobenzoatase.
    Steven FS; Griffin MM; Wong TL; Itzhaki S
    J Enzyme Inhib; 1986; 1(2):127-37. PubMed ID: 3508910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of a protease associated with tumour cells and the probable mechanism of regulation of this interaction in vivo.
    Steven FS; Maier H; Arndt J
    J Enzyme Inhib; 1989; 3(2):145-57. PubMed ID: 2489235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of inhibitors in the fluorescent staining of benign naevus and malignant melanoma cells with 9-amino acridine and acridine orange.
    Steven FS; Suresh U; Wong TL; Griffin MM
    J Enzyme Inhib; 1987; 1(4):275-87. PubMed ID: 3508914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of low-molecular fluorescent dyes for localizing tumor cells].
    Steven FS; Maier H; Born IA; Altmannsberger M
    Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(1):32-5. PubMed ID: 2102400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting adriamycin to tumour cells by means of an affinity ligand; a model system for drug delivery.
    Steven FS; Griffin MM; Williams LA; Ali H; Maier H
    Anticancer Res; 1989; 9(1):247-53. PubMed ID: 2705751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.